Why PEPG? PepGen Inc. Analysis, Price & AI Insights | Whystock
PEPG
$1.75+0.11 (+6.71%)
Market ClosedLast close May 1
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.